Prenetics, a Global Leader in Genomic and Diagnostic Testing, to Become Publicly Traded on the Nasdaq via Merger with Adrian Cheng's Artisan Acquisition Corp.
Go back to Prenetics, a Global Leader in Genomic and Diagnostic Testing, to Become Publicly Traded on the Nasdaq via Merger with Adrian Cheng's Artisan Acquisition Corp.| Aleritas Capital Corp. Units 7/13/2009 (NASDAQ: ARTAU) | Delayed: 10.15 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.15 | 52 Week High | $0.35 | |||
| Open | $10.15 | 52 Week Low | $0.09 | |||
| Day High | $10.15 | P/E | N/A | |||
| Day Low | $10.15 | EPS | $0.00 | |||
| Volume | 4 | |||||
